Analysts

Firm Analyst
Aegis Robert LeBoyer
Cantor Fitzgerald William Tanner, Ph.D.
Cowen and Company Phil Nadeau, Ph.D.
Goldman Sachs Salveen Richter
H.C. Wainwright Raghuram Selvaraju, Ph.D.
Janney Montgomery Scott Ken Trbovich
Jefferies LLC Michael Yee
J.P. Morgan Cory Kasimov
Leerink Paul Matteis
Oppenheimer & Co. Jay Olson
Piper Jaffray & Co. Charles Duncan, Ph.D.
Raymond James Laura K. Chico, Ph.D.
Stifel Nicolaus Thomas Shrader

Acorda Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Acorda Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Acorda Therapeutics, Inc. or its management. Acorda Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Stock Quote

ACOR (Common Stock) $ 21.05 +0.00 (+0%) Volume: 962,102 MORE December 15, 2017

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.